Working… Menu
Trial record 1 of 1 for:    NCT02872116
Previous Study | Return to List | Next Study

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer (CheckMate649)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02872116
Recruitment Status : Active, not recruiting
First Posted : August 19, 2016
Last Update Posted : June 1, 2021
Ono Pharmaceutical Co. Ltd
Information provided by (Responsible Party):
Bristol-Myers Squibb